Chief Scientific Officer · Immunome Inc. (IMNM)

Michael Morin

A named executive officer of Immunome in every fiscal year CompBrief holds from FY2019 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$936,806

Salary $249,385Stock awards $0

FY2019: $363,770

3rd of 3 named executive officers at Immunome by FY2020 total.

3 named officers on file for Immunome, FY2020

Michael Morin’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Immunome’s whole pay program stands against its peers

  • Immunome’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IMNM→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 16, 2021 (DEF 14A).

Free

Get Michael Morin’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Michael Morin compensation by year

Immunome Summary Compensation Table · all 2 fiscal years held
In US dollars, as Immunome reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020
Salary$220,000$249,385
Bonus$0$0
Stock awards$0$0
Option awards$0$559,694
Non-equity incentive$110,000$108,204
Pension and deferred compensation$0$0
All other$33,770$19,523
Total$363,770$936,806

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Immunome Inc. DEF 14A filed April 16, 2021, accession 0001104659-21-051342, and prior-year filings.

How this page was built: the Immunome Inc. filed document, accession 0001104659-21-051342. Every figure is read from that document and cited to the page and table it appears in. Filed April 16, 2021.

$364K
$937K
FY19
FY20
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
Option36,508—$0.54
Option59,696—$2.40
Option40,964—$2.40

Per the Outstanding Equity Awards at Fiscal Year-End table in Immunome Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

Immunome’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Purnanand SarmaPresident, Chief Executive Officer and Director$1,695,002
Sandra StonemanChief Legal Officer and General Counsel$1,314,397
Michael Morin · this pageChief Scientific Officer$936,806

The full Immunome compensation record

free company brief

This page is one person within Immunome's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Immunome's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Michael Morin's compensation dossier · One-time report. No refunds.